Monitoring the Outcome of Phonosurgery and Vocal Exercises with Established and New Diagnostic Tools
Table 2
Changes in vocal measures after treatment for all patients and separated for both intervention groups (logopedics/phonosurgery), both dysphonia groups (functional/organic), and all pathology classification subgroups according to Rosen and Murry [25].
H
VHI-12
VHIs
DSI
VEM
Total group of patients (n = 152)
−0.5 (−0.6; −0.4)
−4.8 (−6.2; −3.3)
−0.7 (−0.8; −0.6)
1.5 (1.0; 2.0)
18.7 (13.4; 24.1)
Logopedic treatment group (n = 79)
−0.3 (−0.4; −0.2)
−1.4 (−2.6; −0.1)
−0.5 (−0.7; −0.4)
0.2 (−0.1; 0.5)
6.5 (1.6; 11.4)
Phonosurgery group (n = 73)
−0.8 (−1.0; −0.6)
−8.5 (−10.9; −6.0)
−0.9 (−1.1; −0.7)
2.8 (1.9; 3.7)
32.0 (22.9; 41.0)
Functional dysphonia group (n = 51)
−0.3 (−0.4; −0.2)
−0.3 (−1.4; 0.7)
−0.5 (−0.7; −0.4)
0.1 (−0.2; 0.4)
3.6 (0.1; 7.1)
Organic dysphonia group (n = 101)
−0.7 (−0.8; −0.5)
−7.0 (−9.0; −5.0)
−0.8 (−1.0; −0.7)
2.2 (1.5; 2.9)
26.4 (18.9; 33.9)
Rosen I subgroup (epithelium) (n = 19)
−0.7 (−1.2; −0.3)
−5.1 (−9.6; −0.6)
−1.0 (−1.3; −0.7)
2.0 (0.5; 3.6)
30.2 (10.1; 50.3)
Rosen II subgroup (lamina propria) (n = 41)
−0.6 (−0.7; −0.4)
−4.6 (−6.8; −2.4)
−0.7 (−0.9; −0.5)
1.2 (0.2; 2.1)
15.7 (7.3; 24.1)
Rosen III subgroup (arytenoid) (n = 5)
−0.1 (−0.4; 0.3)
−1.6 (−6.0; 2.8)
−0.3 (−0.9; 0.3)
0.2 (−0.8; 0.9)
2.5 (−11.8; 16.7)
Rosen IV subgroup (other) (n = 36)
−0.8 (−1.1; −0.5)
−11.5 (−15.7; −7.4)
−1.0 (−1.2; −0.7)
3.9 (2.6; 5.3)
39.9 (24.7; 55.1)
Data expressed as mean differences of preoperative and postoperative values (upper line), with 95% confidence intervals (lower line, in brackets). VEM = vocal extent measure; DSI = dysphonia severity index; VHI-12 = voice handicap index; VHIs = self-perceived impairment of voice at the present time.
